Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NDI Guidance Could Drive Amarin's Gambit To Block Some Omega-3 Imports

May 10 2019

• By Malcolm Spicer

Related Content

Supreme Court Cosmetic, Food Decisions Shape Amarin's Appeal For Omega-3 Trade Inquiry

Dec 05 2017

Revised NDI Notification Draft Guidance Shrinks Divide Between FDA And Industry

Aug 12 2016

Court Tosses Amarin Fair Trade Complaint Against Omega-3 Imports

May 03 2019

Omega-3 Marketers Back Down On Comparisons To Amarin's Vascepa

May 10 2019

NDI Notifications Take Center Stage In FDA's Evaluation Of DSHEA

Apr 10 2019

Related Companies

Amarin Corp plc

Additional Topics

International United States Dietary Supplements FDA Commercial Advertising, Marketing & Sales Business Strategies Compliance Innovation Ingredients Manufacturing Regulation Trade Policy Enforcement Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window